EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Tailored Artificial Biocatalyst for Bacterial Endophthalmitis Therapy via Enhanced Ferroptosis‐Like Death

Caixia Sun, Yingying Jiang, Shibo Zhang, Zhipeng Ding, Lijun Pu, Xinmei Liu, Jun Yang, Xiangkai Zhuge, Jianjun Dai, Yanmin Ju iD

Advanced Science · 2025

DOI: 10.1002/advs.202504601 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Caixia Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, China Pharmaceutical University, Nanjing, 211198, China. Hauptthemen laut MEDLINE: Endophthalmitis, Anti-Bacterial Agents, Ferroptosis, Staphylococcal Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Science and Technology Project of State Administration for Market Regulation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial endophthalmitis is an ophthalmological emergency that can lead to permanent blindness, and high‐efficiency therapeutic strategies that can completely eradicate pathogens within a short timeframe are needed. However, intrinsic limitations of this disease, such as low administration frequency and dosage, render most currently available nano‐antibacterial strategies inapplicable. To address this challenge, a bio‐targeted catalytic strategy that is based on a bacteria‐specific artificial biocatalyst (MoS 2 /Fe@mercaptophenylboronic acid@hyaluronic acid, MFBH) and suitable for treating bacterial endophthalmitis is proposed. The results show that MFBH exhibits high‐efficiency peptidoglycan‐targeted catalytic antibacterial capacity against both standard and clinically isolated strains of Staphylococcus aureus . Notably, the in vivo results demonstrate that MFBH achieves effective treatment of bacterial endophthalmitis at an extremely low dose (≈4 µg kg −1 ) via a single intravitreal injection without causing retinal damage. Importantly, the therapeutic efficacy of MFBH is comparable to that of vancomycin. Mechanistic analysis reveals that MFBH induces enhanced ferroptosis‐like bacterial killing by accelerating reactive oxygen species (ROS) burst. Further investigations show that the generation of abundant ROS is closely associated with the sulfur vacancies and exposed of reactive Mo 4+ on the surface of the prepared artificial biocatalyst. In summary, this bacteria‐specific artificial biocatalyst provides a promising strategy for treating endophthalmitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndophthalmitisAnti-Bacterial AgentsFerroptosisStaphylococcal InfectionsAnimalsStaphylococcus aureusMiceReactive Oxygen SpeciesHumans

Stichwörter der Autor:innen

artificial biocatalystsbacterial endophthalmitisenhanced ferroptosis‐like deathpeptidoglycan targeting

Substanzen

Anti-Bacterial AgentsReactive Oxygen Species

Autor:innen und Institutionen

  • College of Pharmacy, China Pharmaceutical University, Nanjing, 211198, China.
  • Department of Ophthalmology, The Affiliated Zhangjiagang Hospital of Soochow University, Suzhou, 215600, China.
  • Nanjing Institute for Food and Drug Control, Nanjing, 210038, China.
  • School of Public Health, Nantong University, Nantong, 226019, China.
  • MOE Joint International Research Laboratory of Animal Health and Food Safety, Key Laboratory of Animal Bacteriology, Ministry of Agriculture, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, 210…

ORCID-Profile: Yanmin Ju

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • Science and Technology Project of State Administration for Market Regulation
  • Open Project of Jiangsu Provincial Science and Technology Resources (Clinical Resources) Coordination Service Platform

Zitieren

APA

Sun, C., Jiang, Y., Zhang, S., Ding, Z., Pu, L., Liu, X., Yang, J., Zhuge, X., Dai, J., & Ju, Y. (2025). A Tailored Artificial Biocatalyst for Bacterial Endophthalmitis Therapy via Enhanced Ferroptosis‐Like Death. Advanced Science. https://doi.org/10.1002/advs.202504601

Vancouver

Sun C, Jiang Y, Zhang S, Ding Z, Pu L, Liu X, et al. A Tailored Artificial Biocatalyst for Bacterial Endophthalmitis Therapy via Enhanced Ferroptosis‐Like Death. Advanced Science. 2025. doi:10.1002/advs.202504601

BibTeX
@article{Sun2025,
  author = {Sun, Caixia and Jiang, Yingying and Zhang, Shibo and Ding, Zhipeng and Pu, Lijun and Liu, Xinmei and Yang, Jun and Zhuge, Xiangkai and Dai, Jianjun and Ju, Yanmin},
  title = {A Tailored Artificial Biocatalyst for Bacterial Endophthalmitis Therapy via Enhanced Ferroptosis‐Like Death},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202504601}
}
Kostenlos starten →